RecentMedicalFindings.com
Summarizing relevant biomedical research!
phenomenon vasomotor     Bookmark and Share
Search webpages of this site (RecentMedicalFindings):
Didn't find what you wanted? Try it at BioMedLib™ !
Search directly on the biomedical articles using BioMedLib™ search engine:



1. Biomedical articles (top 31; 2009 to 2014)
1. |||||..... 50%  Maas JJ, de Wilde RB, Aarts LP, Pinsky MR, Jansen JR: Determination of vascular waterfall phenomenon by bedside measurement of mean systemic filling pressure and critical closing pressure in the intensive care unit. Anesth Analg; 2012 Apr;114(4):803-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Determination of vascular waterfall phenomenon by bedside measurement of mean systemic filling pressure and critical closing pressure in the intensive care unit.
  • CONCLUSIONS: Vascular pressure gradients in cardiac surgery patients suggest the presence of a vascular waterfall phenomenon, which is not affected by CO.
  • Thus, measures of total systemic vascular resistance may become irrelevant in assessing systemic vasomotor tone.

  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Circ Res. 1978 Jul;43(1):92-101 [657462.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2004 Jun;286(6):H2376-85 [14764438.001]
  • [Cites] Am J Physiol. 1980 Jun;238(6):H823-8 [7386641.001]
  • [Cites] Circ Res. 1981 Oct;49(4):980-7 [6791862.001]
  • [Cites] J Appl Physiol Respir Environ Exerc Physiol. 1984 Mar;56(3):765-71 [6368503.001]
  • [Cites] Am J Physiol. 1984 May;246(5 Pt 2):H702-9 [6720982.001]
  • [Cites] Pflugers Arch. 1985 Oct;405(3):226-33 [4069980.001]
  • [Cites] Circ Res. 1990 Jul;67(1):209-20 [2364491.001]
  • [Cites] J Appl Physiol (1985). 1993 Feb;74(2):499-509 [8458763.001]
  • [Cites] J Appl Physiol (1985). 1993 May;74(5):2566-73 [8335593.001]
  • [Cites] Am J Physiol. 1994 Dec;267(6 Pt 2):H2255-8 [7810725.001]
  • [Cites] Br J Anaesth. 1996 Sep;77(3):399-403 [8949819.001]
  • [Cites] Am J Physiol. 1951 Feb;164(2):319-29 [14810937.001]
  • [Cites] Am J Physiol. 1954 Nov;179(2):261-7 [13218155.001]
  • [Cites] Physiol Rev. 1955 Jan;35(1):123-9 [14356924.001]
  • [Cites] J Appl Physiol. 1963 Sep;18:924-32 [14063262.001]
  • [Cites] Br J Anaesth. 2005 May;94(5):577-81 [15722386.001]
  • [Cites] Anesthesiology. 2005 Jul;103(1):20-4 [15983452.001]
  • [Cites] Anaesthesia. 2007 Aug;62(8):760-8 [17635422.001]
  • [Cites] Anesthesiology. 2009 Feb;110(2):370-9 [19194163.001]
  • [Cites] Crit Care Med. 2009 Mar;37(3):912-8 [19237896.001]
  • [Cites] J Appl Physiol (1985). 2000 Mar;88(3):926-32 [10710387.001]
  • [Cites] J Neurosurg Anesthesiol. 2000 Jul;12(3):210-6 [10905568.001]
  • [Cites] Br J Anaesth. 2001 Aug;87(2):212-22 [11493492.001]
  • [Cites] Intensive Care Med. 2001 Sep;27(9):1446-58 [11685337.001]
  • [Cites] J Appl Physiol (1985). 2002 Mar;92(3):1223-31 [11842062.001]
  • [Cites] Stroke. 2003 Jul;34(7):1645-9 [12791944.001]
  • [Cites] Resuscitation. 2003 Sep;58(3):249-58 [12969599.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2003 Dec;285(6):H2510-5 [12907428.001]
  • [Cites] Am J Physiol. 1979 Nov;237(5):H584-9 [495764.001]
  • (PMID = 22344243.001).
  • [ISSN] 1526-7598
  • [Journal-full-title] Anesthesia and analgesia
  • [ISO-abbreviation] Anesth. Analg.
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / HL67181; United States / NHLBI NIH HHS / HL / K24 HL067181; United States / NHLBI NIH HHS / HL / K24 HL067181-01A1
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS352056; NLM/ PMC3310263
  •  go-up   go-down


2. ||||...... 44%  Rosenthal J, Colachis S: Cortical blindness associated with autonomic dysreflexia in a man with tetraplegia: a rare but serious complication. J Spinal Cord Med; 2011;34(5):527-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Conclusion/clinical relevance: This case illustrates a possible profound vasomotor phenomenon (cortical blindness) associated with AD and its symptomatic treatment.

  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Spinal Cord. 2002 Mar;40(3):142-4 [11859441.001]
  • [Cites] Arch Phys Med Rehabil. 1986 Nov;67(11):834-5 [3778184.001]
  • [Cites] Spinal Cord. 1999 Jun;37(6):383-91 [10432257.001]
  • [Cites] Spinal Cord. 2011 Jan;49(1):49-54 [20697419.001]
  • [Cites] Arch Phys Med Rehabil. 2009 Apr;90(4):682-95 [19345787.001]
  • [Cites] J Headache Pain. 2010 Jun;11(3):277-80 [20186562.001]
  • [Cites] Spinal Cord. 2008 Nov;46(11):760-1 [18427565.001]
  • (PMID = 22118262.001).
  • [ISSN] 1079-0268
  • [Journal-full-title] The journal of spinal cord medicine
  • [ISO-abbreviation] J Spinal Cord Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3184492
  •  go-up   go-down


3. |||....... 31%  Singh S, Sankar J, Dubey N: Non-cardiogenic pulmonary oedema following accidental electrocution in a toddler. BMJ Case Rep; 2011;2011
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Non-cardiogenic pulmonary oedema is an uncommonly recognised entity which occurs with any neurological or non-neurological event stimulating the vasomotor centres.
  • There are divergent theories to explain the cause for this rare phenomenon but none has been proved.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurosurg Anesthesiol. 2003 Apr;15(2):144-50 [12658001.001]
  • [Cites] Am Rev Respir Dis. 1976 Apr;113(4):405-11 [178254.001]
  • [Cites] Neurol Clin. 1993 May;11(2):309-23 [8316188.001]
  • [Cites] Changgeng Yi Xue Za Zhi. 1994 Sep;17(3):220-5 [7954000.001]
  • [Cites] N Engl J Med. 1995 Jan 5;332(1):27-37 [7646623.001]
  • [Cites] Burns. 1995 Nov;21(7):530-5 [8540982.001]
  • [Cites] Chest. 1997 May;111(5):1326-33 [9149590.001]
  • [Cites] J Burn Care Rehabil. 2004 Nov-Dec;25(6):479-84 [15534455.001]
  • (PMID = 22696624.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3082062
  •  go-up   go-down


Advertisement

4. |||....... 31%  Kapela A, Nagaraja S, Parikh J, Tsoukias NM: Modeling Ca2+ signaling in the microcirculation: intercellular communication and vasoreactivity. Crit Rev Biomed Eng; 2011;39(5):435-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This phenomenon is critical for both short-term changes in blood perfusion as well as long-term adaptations of a vascular network.
  • In addition, in a phenomenon termed vasomotion, arterioles often exhibit spontaneous oscillations in diameter.
  • [MeSH-major] Calcium / metabolism. Calcium Signaling / physiology. Endothelium, Vascular / physiology. Microcirculation / physiology. Models, Cardiovascular. Vasomotor System / physiology

  • HSDB. structure - CALCIUM, ELEMENTAL.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Phys Med Biol. 1999 Oct;44(10):N217-21 [10533937.001]
  • [Cites] Cardiovasc Res. 1999 Oct;44(1):176-84 [10615401.001]
  • [Cites] Circ Res. 2000 Feb 18;86(3):341-6 [10679487.001]
  • [Cites] Braz J Med Biol Res. 2000 Apr;33(4):369-78 [10775301.001]
  • [Cites] Braz J Med Biol Res. 2000 Apr;33(4):415-22 [10775306.001]
  • [Cites] J Auton Nerv Syst. 2000 Jul 3;81(1-3):122-7 [10869710.001]
  • [Cites] J Nucl Cardiol. 2000 Sep-Oct;7(5):496-9 [11083199.001]
  • [Cites] Ann Biomed Eng. 2000 Aug;28(8):945-50 [11144679.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H1088-96 [11179051.001]
  • [Cites] J Physiol. 2001 Mar 1;531(Pt 2):359-73 [11230509.001]
  • [Cites] Microcirculation. 2001 Feb;8(1):33-43 [11296851.001]
  • [Cites] Stroke. 2007 Jan;38(1):124-30 [17122418.001]
  • [Cites] Circ Res. 2007 Feb 2;100(2):246-54 [17218602.001]
  • [Cites] J Physiol. 2007 Feb 15;579(Pt 1):175-86 [17138602.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2007 Mar;292(3):H1634-40 [17098832.001]
  • [Cites] Placenta. 2007 Apr;28(4):328-38 [16797694.001]
  • [Cites] Am J Physiol Cell Physiol. 2007 Jul;293(1):C277-93 [17459942.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H229-37 [17369467.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H215-28 [17369468.001]
  • [Cites] Biophys J. 2007 Sep 1;93(5):1534-56 [17483163.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1371-83 [17513486.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H2007; author reply H2008 [17804398.001]
  • [Cites] Cell Calcium. 2007 Dec;42(6):536-47 [17524481.001]
  • [Cites] Circ Res. 2007 Dec 7;101(12):1292-9 [17932322.001]
  • [Cites] Circ Res. 2007 Dec 7;101(12):1300-9 [17932328.001]
  • [Cites] Pharmacol Rep. 2008 Jan-Feb;60(1):68-74 [18276987.001]
  • [Cites] Biophys J. 2008 Mar 15;94(6):2404-11 [18065468.001]
  • [Cites] Am J Physiol Cell Physiol. 2008 Mar;294(3):C856-66 [18160488.001]
  • [Cites] Circ Res. 2008 May 23;102(10):1247-55 [18403729.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2898-904 [18408134.001]
  • [Cites] Cell Calcium. 2008 Aug;44(2):135-46 [18191200.001]
  • [Cites] J Theor Biol. 2008 Jul 21;253(2):238-60 [18423672.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9627-32 [18621682.001]
  • [Cites] J Vasc Res. 2008;45(5):416-26 [18401180.001]
  • [Cites] Philos Trans A Math Phys Eng Sci. 2008 Oct 13;366(1880):3483-502 [18632459.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1562-71 [18689501.001]
  • [Cites] J Cell Sci. 2008 Nov 1;121(Pt 21):3664-73 [18946029.001]
  • [Cites] J Physiol. 2008 Nov 1;586(Pt 21):5047-61 [18787034.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2001-7 [18790841.001]
  • [Cites] Pflugers Arch. 2008 Nov;457(2):389-404 [18536933.001]
  • [Cites] Clin Exp Pharmacol Physiol. 2009 Jan;36(1):67-76 [19018806.001]
  • [Cites] J Anat. 2009 Feb;214(2):258-66 [19207987.001]
  • [Cites] Microcirculation. 2009 May;16(4):307-22 [19330678.001]
  • [Cites] J Vasc Res. 2009;46(3):253-64 [18984964.001]
  • [Cites] Cardiovasc Res. 2009 Jun 1;82(3):476-83 [19218287.001]
  • [Cites] J Theor Biol. 2009 Jul 21;259(2):242-52 [19303886.001]
  • [Cites] Microcirculation. 2009 Nov;16(8):694-713 [19905969.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2010 Jan;298(1):H52-65 [19855062.001]
  • [Cites] Cardiovasc Res. 2010 Feb 1;85(3):604-13 [19820254.001]
  • [Cites] FEBS J. 2010 Jan;277(2):278-85 [19895582.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2010 Feb;298(2):H488-96 [19966061.001]
  • [Cites] Circ J. 2010 Feb;74(2):226-32 [20065608.001]
  • [Cites] J Vasc Res. 2010;47(2):93-107 [19729956.001]
  • [Cites] Pflugers Arch. 2010 May;459(6):897-914 [20379740.001]
  • [Cites] Pflugers Arch. 2010 May;459(6):863-79 [20383718.001]
  • [Cites] Pflugers Arch. 2010 Jun;460(1):41-53 [20383716.001]
  • [Cites] Clin Exp Pharmacol Physiol. 2010 May;37(5-6):536-43 [20529092.001]
  • [Cites] J Vasc Res. 2011;48(1):79-89 [20639650.001]
  • [Cites] Wiley Interdiscip Rev Syst Biol Med. 2011 Jan-Feb;3(1):93-106 [21061306.001]
  • [Cites] Acta Physiol (Oxf). 2011 Feb;201(2):193-218 [20887358.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2001 Jun;280(6):H2424-9 [11356594.001]
  • [Cites] J Theor Biol. 2001 Mar 21;209(2):189-99 [11401461.001]
  • [Cites] Nat Rev Mol Cell Biol. 2000 Oct;1(1):11-21 [11413485.001]
  • [Cites] Circ Res. 2001 Apr 27;88(8):810-5 [11325873.001]
  • [Cites] J Physiol. 2001 Aug 1;534(Pt 3):641-50 [11483697.001]
  • [Cites] J Appl Physiol (1985). 2001 Sep;91(3):1438-49 [11509546.001]
  • [Cites] Physiol Rev. 2001 Oct;81(4):1415-59 [11581493.001]
  • [Cites] Circulation. 2001 Oct 9;104(15):1749-53 [11591608.001]
  • [Cites] Annu Rev Biomed Eng. 2000;2:119-55 [11701509.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1115-22 [11830654.001]
  • [Cites] Science. 2002 Mar 1;295(5560):1678-82 [11872832.001]
  • [Cites] Circ Res. 2002 May 31;90(10):1108-13 [12039801.001]
  • [Cites] Clin Exp Pharmacol Physiol. 2002 Jul;29(7):595-602 [12060103.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2002 Jul;283(1):H102-9 [12063280.001]
  • [Cites] Br J Pharmacol. 2002 Jul;136(6):918-26 [12110616.001]
  • [Cites] Cell Calcium. 2002 Sep;32(3):105-20 [12208231.001]
  • [Cites] Life Sci. 2002 Oct 25;71(23):2713-28 [12383879.001]
  • [Cites] J Physiol. 2002 Dec 1;545(Pt 2):615-27 [12456838.001]
  • [Cites] Circ Res. 2003 Apr 18;92(7):793-800 [12637364.001]
  • [Cites] Phys Rev E Stat Nonlin Soft Matter Phys. 2003 May;67(5 Pt 1):051922 [12786193.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2003 Jul;285(1):H119-26 [12793976.001]
  • [Cites] Eur Biophys J. 2003 Jul;32(4):370-80 [12851795.001]
  • [Cites] Circ Res. 2003 Jul 11;93(1):61-8 [12791708.001]
  • [Cites] Circ Res. 2003 Jul 11;93(1):9-11 [12855671.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H562-9 [12574002.001]
  • [Cites] Med Eng Phys. 2003 Oct;25(8):691-709 [12900184.001]
  • [Cites] Med Eng Phys. 2003 Oct;25(8):711-7 [12900185.001]
  • [Cites] Annu Rev Biomed Eng. 2003;5:147-77 [14527312.001]
  • [Cites] J Vasc Res. 2003 Sep-Oct;40(5):480-90 [14583659.001]
  • [Cites] J Physiol. 2003 Nov 15;553(Pt 1):183-9 [14555724.001]
  • [Cites] J Gen Physiol. 2004 Feb;123(2):121-34 [14718479.001]
  • [Cites] Mol Interv. 2003 Mar;3(2):79-89, 51 [14993429.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1573-89 [14656705.001]
  • [Cites] J Cardiovasc Pharmacol. 2004 Apr;43(4):539-48 [15085065.001]
  • [Cites] J Physiol. 2004 May 1;556(Pt 3):875-86 [14766938.001]
  • [Cites] J Physiol. 2004 May 1;556(Pt 3):887-903 [14966304.001]
  • [Cites] Prog Biophys Mol Biol. 2004 Jun-Jul;85(2-3):261-78 [15142747.001]
  • [Cites] Clin Exp Pharmacol Physiol. 2004 May-Jun;31(5-6):354-9 [15191411.001]
  • [Cites] Biophys J. 2004 Jul;87(1):92-104 [15240448.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H608-16 [15059779.001]
  • [Cites] Microcirculation. 2004 Jul-Aug;11(5):425-33 [15280068.001]
  • [Cites] Physiology (Bethesda). 2004 Aug;19:191-7 [15304633.001]
  • [Cites] Physiology (Bethesda). 2004 Oct;19:277-84 [15381756.001]
  • [Cites] Clin Exp Pharmacol Physiol. 2004 Sep;31(9):563-70 [15479161.001]
  • [Cites] Clin Exp Pharmacol Physiol. 2004 Sep;31(9):650-5 [15479174.001]
  • [Cites] Biophys J. 2004 Nov;87(5):3351-71 [15347581.001]
  • [Cites] Circ Res. 1970 Feb;26(2):163-70 [5412532.001]
  • [Cites] J Appl Physiol. 1973 Jul;35(1):90-4 [4716167.001]
  • [Cites] J Physiol. 1978 Jul;280:87-104 [690942.001]
  • [Cites] Nature. 1980 Nov 27;288(5789):373-6 [6253831.001]
  • [Cites] Eur Neurol. 1981;20(6):448-68 [6118276.001]
  • [Cites] J Cereb Blood Flow Metab. 1982 Dec;2(4):421-8 [7142306.001]
  • [Cites] Am J Physiol. 1982 Dec;243(6):H837-43 [7149040.001]
  • [Cites] Am J Physiol. 1985 Mar;248(3 Pt 2):H419-23 [2579588.001]
  • [Cites] Nature. 1987 Jun 11-17;327(6122):524-6 [3495737.001]
  • [Cites] Am J Physiol. 1987 Sep;253(3 Pt 2):H568-73 [3631294.001]
  • [Cites] Am J Physiol. 1988 Jan;254(1 Pt 2):H67-71 [3337261.001]
  • [Cites] Br J Pharmacol. 1988 Dec;95(4):1165-74 [2851359.001]
  • [Cites] Annu Rev Physiol. 1989;51:315-29 [2653185.001]
  • [Cites] Int J Microcirc Clin Exp. 1989 Apr;8(2):205-15 [2659545.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Feb;87(4):1461-5 [2304911.001]
  • [Cites] Pflugers Arch. 1990 May;416(3):305-11 [2381766.001]
  • [Cites] Cell. 1991 Mar 22;64(6):1057-68 [1672265.001]
  • [Cites] J Physiol. 1990 Nov;430:389-98 [2086768.001]
  • [Cites] Am J Physiol. 1991 Jul;261(1 Pt 2):H181-9 [1858919.001]
  • [Cites] Circ Res. 1992 Apr;70(4):660-9 [1551193.001]
  • [Cites] Cardiovasc Res. 1992 Jan;26(1):40-7 [1325292.001]
  • [Cites] J Appl Physiol (1985). 1992 Sep;73(3):1077-83 [1400020.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9895-9 [1329108.001]
  • [Cites] Basic Res Cardiol. 1992 Jul-Aug;87(4):317-32 [1358060.001]
  • [Cites] Biophys J. 1992 Jul;63(1):235-46 [1420870.001]
  • [Cites] Acta Physiol Scand. 1993 Jan;147(1):9-13 [8095768.001]
  • [Cites] Cell Calcium. 1993 Mar;14(3):227-43 [8388778.001]
  • [Cites] J Biomech Eng. 1993 May;115(2):160-8 [8392123.001]
  • [Cites] Acta Physiol Scand Suppl. 1993;614:1-44 [8128886.001]
  • [Cites] Math Biosci. 1994 Feb;119(2):127-67 [8142694.001]
  • [Cites] Mol Cell Endocrinol. 1994 Jan;98(2):173-87 [8143927.001]
  • [Cites] Am J Physiol. 1994 Mar;266(3 Pt 2):H952-8 [8160843.001]
  • [Cites] Circ Res. 1994 Jun;74(6):1071-96 [7514509.001]
  • [Cites] Am J Physiol. 1995 Aug;269(2 Pt 2):F198-204 [7653593.001]
  • [Cites] Am J Physiol Renal Physiol. 2007 Jun;292(6):F1827-45 [17311908.001]
  • [Cites] Am J Physiol. 1995 Dec;269(6 Pt 2):H2155-61 [8594927.001]
  • [Cites] J Physiol. 2007 Jul 1;582(Pt 1):335-47 [17478526.001]
  • [Cites] Am J Physiol. 1996 May;270(5 Pt 1):C1556-69 [8967458.001]
  • [Cites] Circ Res. 1996 Oct;79(4):631-46 [8831487.001]
  • [Cites] Ann Biomed Eng. 1996 Sep-Oct;24(5):547-60 [8886236.001]
  • [Cites] J Cell Physiol. 1996 Nov;169(2):358-63 [8908203.001]
  • [Cites] J Physiol. 1996 Oct 1;496 ( Pt 1):229-44 [8910211.001]
  • [Cites] J Cardiovasc Pharmacol. 1996 Nov;28(5):703-11 [8945685.001]
  • [Cites] Pflugers Arch. 1997 Jan;433(3):364-7 [9064654.001]
  • [Cites] Annu Rev Physiol. 1997;59:145-70 [9074759.001]
  • [Cites] Am J Physiol. 1997 Mar;272(3 Pt 2):H1364-71 [9087613.001]
  • [Cites] Am J Physiol. 1997 May;272(5 Pt 2):H2306-12 [9176299.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6529-34 [9177252.001]
  • [Cites] Biophys J. 1997 Aug;73(2):659-73 [9251785.001]
  • [Cites] J Biol Chem. 1998 Feb 13;273(7):4052-8 [9461597.001]
  • [Cites] Biophys J. 1998 Mar;74(3):1149-68 [9512016.001]
  • [Cites] Microvasc Res. 1998 Jul;56(1):43-53 [9683562.001]
  • [Cites] Am J Physiol. 1998 Aug;275(2 Pt 2):H349-60 [9683420.001]
  • [Cites] Nature. 1998 Nov 19;396(6708):269-72 [9834033.001]
  • [Cites] J Physiol. 1999 Apr 1;516 ( Pt 1):283-91 [10066941.001]
  • [Cites] Am J Physiol. 1999 Mar;276(3 Pt 2):H1107-12 [10070099.001]
  • [Cites] Biophys J. 1999 Jul;77(1):617-28 [10388786.001]
  • [Cites] Am J Physiol. 1999 Sep;277(3 Pt 2):H1119-44 [10484436.001]
  • [Cites] Acta Physiol Scand. 1999 Sep;167(1):11-21 [10519972.001]
  • [Cites] J Biophys Biochem Cytol. 1957 May 25;3(3):457-62 [13438930.001]
  • [Cites] J Physiol. 2004 Nov 15;561(Pt 1):215-31 [15550469.001]
  • [Cites] Circ Res. 2004 Dec 10;95(12):1216-24 [15528464.001]
  • [Cites] J Theor Biol. 2005 May 7;234(1):107-22 [15721040.001]
  • [Cites] J Physiol. 2005 Mar 1;563(Pt 2):541-55 [15576454.001]
  • [Cites] Cell Calcium. 2005 Apr;37(4):311-20 [15755492.001]
  • [Cites] Br J Pharmacol. 2005 Mar;144(5):605-16 [15678091.001]
  • [Cites] Microcirculation. 2005 Jan-Feb;12(1):33-45 [15804972.001]
  • [Cites] Biophys J. 2005 Jun;88(6):3845-54 [15792979.001]
  • [Cites] J Biol Chem. 2005 Jun 10;280(23):21837-46 [15788407.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H886-97 [15833804.001]
  • [Cites] Med Biol Eng Comput. 2005 May;43(3):387-94 [16035228.001]
  • [Cites] J Physiol. 2005 Aug 1;566(Pt 3):645-56 [15905215.001]
  • [Cites] J Vasc Res. 2005 Jul-Aug;42(4):301-11 [15925896.001]
  • [Cites] Europace. 2005 Sep;7 Suppl 2:118-27 [16102509.001]
  • [Cites] Circ Res. 2005 Aug 19;97(4):399-407 [16037574.001]
  • [Cites] Bull Math Biol. 2005 Nov;67(6):1253-72 [15998534.001]
  • [Cites] Physiology (Bethesda). 2005 Oct;20:316-25 [16174871.001]
  • [Cites] J Physiol. 2005 Oct 1;568(Pt 1):267-81 [16002449.001]
  • [Cites] J Smooth Muscle Res. 2005 Dec;41(6):303-11 [16557004.001]
  • [Cites] Cell Calcium. 2006 Jul;40(1):29-40 [16697039.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H385-93 [16443675.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1319-28 [16617135.001]
  • [Cites] Biophys J. 2006 Sep 1;91(5):1663-74 [16751242.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1761-7 [16731646.001]
  • [Cites] J Anat. 2006 Nov;209(5):689-98 [17062025.001]
  • [Cites] Br J Pharmacol. 2003 Feb;138(4):594-601 [12598413.001]
  • [Cites] Circ Res. 1996 Jan;78(1):148-53 [8603497.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):822-8 [12649082.001]
  • [Cites] Ann Biomed Eng. 1995 Nov-Dec;23(6):822-32 [8572432.001]
  • (PMID = 22196162.001).
  • [ISSN] 0278-940X
  • [Journal-full-title] Critical reviews in biomedical engineering
  • [ISO-abbreviation] Crit Rev Biomed Eng
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / HL095101; United States / NHLBI NIH HHS / HL / SC1 HL095101; United States / NHLBI NIH HHS / HL / SC1 HL095101-04
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] United States
  • [Chemical-registry-number] SY7Q814VUP / Calcium
  • [Other-IDs] NLM/ NIHMS448623; NLM/ PMC3681513
  •  go-up   go-down


5. |||....... 31%  Tran CH, Vigmond EJ, Goldman D, Plane F, Welsh DG: Electrical communication in branching arterial networks. Am J Physiol Heart Circ Physiol; 2012 Sep 15;303(6):H680-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An elevation in endothelial-endothelial coupling resistance, akin to those in sepsis models, compromised this ascension of vasomotor/perfusion responses.
  • In closing, this study highlights that vessel length and branching play a role in setting the conduction of electrical phenomenon along resistance arteries and within networks.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H861-70 [15486033.001]
  • [Cites] Am J Physiol. 1993 Jul;265(1 Pt 2):H350-65 [8342652.001]
  • [Cites] Circ Res. 2000 Jan 7-21;86(1):94-100 [10625310.001]
  • [Cites] Circ Res. 2000 Feb 18;86(3):341-6 [10679487.001]
  • [Cites] J Cell Physiol. 2000 Oct;185(1):117-25 [10942525.001]
  • [Cites] J Theor Biol. 2000 Sep 21;206(2):181-94 [10966756.001]
  • [Cites] Circ Res. 2000 Sep 15;87(6):474-9 [10988239.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2001 Jun;280(6):H2478-83 [11356601.001]
  • [Cites] J Physiol. 2001 Aug 15;535(Pt 1):181-95 [11507168.001]
  • [Cites] J Physiol. 2001 Nov 1;536(Pt 3):937-46 [11691885.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):225-30 [11834520.001]
  • [Cites] Clin Exp Pharmacol Physiol. 2002 Jul;29(7):620-5 [12060107.001]
  • [Cites] Arteriosclerosis. 1985 May-Jun;5(3):293-302 [3994585.001]
  • [Cites] Science. 1986 Nov 14;234(4778):868-70 [3775368.001]
  • [Cites] Circ Res. 1990 Oct;67(4):826-34 [2208609.001]
  • [Cites] J Physiol. 1991;440:325-43 [1804966.001]
  • [Cites] Am J Physiol. 1992 Jul;263(1 Pt 2):H1-7 [1636748.001]
  • [Cites] Circ Res. 1992 Nov;71(5):1200-12 [1394880.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1319-28 [16617135.001]
  • [Cites] J Cell Physiol. 2007 Apr;211(1):159-66 [17149706.001]
  • [Cites] Circ Res. 1994 Nov;75(5):904-15 [7923637.001]
  • [Cites] J Clin Invest. 1994 Nov;94(5):2077-83 [7962554.001]
  • [Cites] Am J Physiol. 1995 Feb;268(2 Pt 2):H729-39 [7864199.001]
  • [Cites] Am J Physiol. 1995 Nov;269(5 Pt 2):H1723-8 [7503270.001]
  • [Cites] J Physiol. 1996 Oct 1;496 ( Pt 1):229-44 [8910211.001]
  • [Cites] Am J Physiol. 1998 Jan;274(1 Pt 2):H178-86 [9458866.001]
  • [Cites] Biochem Biophys Res Commun. 1999 Jan 8;254(1):27-31 [9920727.001]
  • [Cites] J Physiol. 1959 Dec;149:93-111 [14401838.001]
  • [Cites] J Physiol. 2007 Feb 15;579(Pt 1):175-86 [17138602.001]
  • [Cites] Antioxid Redox Signal. 2008 Sep;10(9):1631-74 [18598143.001]
  • [Cites] J Cell Physiol. 2008 Nov;217(2):350-9 [18521823.001]
  • [Cites] J Physiol. 2009 Mar 15;587(Pt 6):1301-18 [19171655.001]
  • [Cites] J Physiol. 2005 Oct 1;568(Pt 1):267-81 [16002449.001]
  • (PMID = 22796538.001).
  • [ISSN] 1522-1539
  • [Journal-full-title] American journal of physiology. Heart and circulatory physiology
  • [ISO-abbreviation] Am. J. Physiol. Heart Circ. Physiol.
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / R01 HL101196
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3774495
  •  go-up   go-down


6. |||....... 31%  Kokolus KM, Hong CC, Repasky EA: Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor? Int J Hyperthermia; 2010;26(7):662-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • While the literature reveals a strong link between treatment for breast cancer and some menopausal vasomotor symptoms (e.g. hot flashes also known as "hot flushes"), there is little data on quantitative assessment of severity of different types of symptoms and their possible prognostic potential.
  • In comparison to reports on the phenomenon of breast cancer-associated hot flashes, there is essentially no scientific study on the large number of women who report feeling excessively cold after breast cancer treatment.
  • In general, there is surprisingly little information on the physiological relationship between body temperature regulation, vasomotor symptoms, and cancer growth and progression.

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 1998 Feb;16(2):495-500 [9469333.001]
  • [Cites] Cancer Nurs. 1998 Apr;21(2):143-8 [9556941.001]
  • [Cites] Cancer. 1998 May 1;82(9):1682-91 [9576289.001]
  • [Cites] Cancer. 1998 May 1;82(9):1784-8 [9576302.001]
  • [Cites] Ann Intern Med. 2000 May 16;132(10):788-93 [10819701.001]
  • [Cites] Fertil Steril. 2000 Jul;74(1):20-3 [10899491.001]
  • [Cites] Exerc Sport Sci Rev. 2000 Jul;28(3):108-12 [10916701.001]
  • [Cites] Semin Oncol Nurs. 2000 Aug;16(3):214-25 [10967794.001]
  • [Cites] Clin Infect Dis. 2000 Oct;31 Suppl 5:S157-61 [11113018.001]
  • [Cites] Clin Infect Dis. 2000 Oct;31 Suppl 5:S178-84 [11113021.001]
  • [Cites] J Leukoc Biol. 2000 Dec;68(6):815-20 [11129648.001]
  • [Cites] Lancet. 2000 Dec 16;356(9247):2059-63 [11145492.001]
  • [Cites] Int J Clin Pharmacol Res. 2000;20(1-2):41-6 [11146901.001]
  • [Cites] Cell Stress Chaperones. 2000 Nov;5(5):458-61 [11189452.001]
  • [Cites] Cell. 2001 Feb 23;104(4):531-43 [11239410.001]
  • [Cites] Am J Epidemiol. 2001 Apr 15;153(8):790-3 [11296152.001]
  • [Cites] J Clin Oncol. 2001 May 15;19(10):2739-45 [11352967.001]
  • [Cites] Menopause. 2001 May-Jun;8(3):181-8 [11355040.001]
  • [Cites] Br J Nutr. 2001 Jun;85(6):715-23 [11430776.001]
  • [Cites] Cancer. 2001 Sep 15;92(6 Suppl):1684-8 [11598887.001]
  • [Cites] J Nutr. 2001 Nov;131(11 Suppl):3109S-20S [11694656.001]
  • [Cites] Trends Neurosci. 2002 Mar;25(3):154-9 [11852148.001]
  • [Cites] BJU Int. 2002 Mar;89(4):379-83 [11872028.001]
  • [Cites] J Clin Oncol. 2002 Mar 15;20(6):1449-55 [11896091.001]
  • [Cites] J Appl Physiol Respir Environ Exerc Physiol. 1978 Jan;44(1):1-4 [627489.001]
  • [Cites] Lancet. 1978 Apr 1;1(8066):678-81 [76222.001]
  • [Cites] Science. 1978 Jul 7;201(4350):16-22 [351802.001]
  • [Cites] J Appl Physiol Respir Environ Exerc Physiol. 1982 Sep;53(3):671-6 [7129989.001]
  • [Cites] Am J Physiol. 1984 Aug;247(2 Pt 1):E181-9 [6380306.001]
  • [Cites] Pediatrics. 1984 Nov;74(5 Pt 2):929-36 [6333668.001]
  • [Cites] Clin Endocrinol Metab. 1984 Nov;13(3):581-95 [6391756.001]
  • [Cites] Biochem Biophys Res Commun. 1985 Jun 28;129(3):826-32 [3893432.001]
  • [Cites] J Clin Invest. 1986 Dec;78(6):1568-78 [3782471.001]
  • [Cites] Neurotoxicology. 1986 Fall;7(3):97-106 [3822265.001]
  • [Cites] Pharmacol Ther. 1987;35(1-2):163-215 [3321099.001]
  • [Cites] Am J Clin Oncol. 1992 Apr;15(2):125-8 [1553899.001]
  • [Cites] Ann Oncol. 2000 Jan;11(1):17-22 [10690382.001]
  • [Cites] J Clin Oncol. 2000 Mar;18(5):1068-74 [10694559.001]
  • [Cites] Am J Physiol Regul Integr Comp Physiol. 2000 Mar;278(3):R545-55 [10712271.001]
  • [Cites] Menopause. 2000 Mar-Apr;7(2):105-11 [10746892.001]
  • [Cites] Eur J Neurosci. 2006 Jun;23(12):3359-67 [16820025.001]
  • [Cites] Menopause. 2006 Jul-Aug;13(4):568-75 [16837878.001]
  • [Cites] Am J Pathol. 2006 Nov;169(5):1505-22 [17071576.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Dec;91(12):4805-8 [17018658.001]
  • [Cites] Nature. 2006 Dec 14;444(7121):847-53 [17167472.001]
  • [Cites] Oncologist. 2007 Jan;12(1):124-35 [17227907.001]
  • [Cites] Ann Oncol. 2007 Apr;18(4):689-93 [17229772.001]
  • [Cites] JAMA. 2007 Apr 4;297(13):1465-77 [17405972.001]
  • [Cites] Neurosci Lett. 2007 May 17;418(2):117-21 [17403578.001]
  • [Cites] Clin Ther. 2007 Feb;29(2):230-41 [17472816.001]
  • [Cites] Prog Lipid Res. 2007 Mar;46(2):89-107 [17275915.001]
  • [Cites] Psychooncology. 2007 May;16(5):487-92 [17048223.001]
  • [Cites] Menopause. 2007 Mar-Apr;14(2):191-202 [17194963.001]
  • [Cites] Oncol Nurs Forum. 2007 Jan;34(1):93-9 [17562637.001]
  • [Cites] Qual Life Res. 2007 Aug;16(6):947-60 [17457697.001]
  • [Cites] J Leukoc Biol. 2007 Nov;82(5):1322-31 [17711975.001]
  • [Cites] J Clin Oncol. 2007 Dec 10;25(35):5584-90 [18065731.001]
  • [Cites] Lancet Oncol. 2010 Jun;11(6):561-70 [20434400.001]
  • [Cites] J Intern Med. 2010 Jun;267(6):543-60 [20210843.001]
  • [Cites] Int J Hyperthermia. 2010;26(5):514-21 [20377362.001]
  • [Cites] Comp Biochem Physiol A Comp Physiol. 1987;88(3):519-21 [2892627.001]
  • [Cites] Pflugers Arch. 1987 Nov;410(4-5):567-87 [3324054.001]
  • [Cites] J Clin Oncol. 1989 Jan;7(1):115-8 [2491882.001]
  • [Cites] Am J Physiol. 1989 Mar;256(3 Pt 2):R733-8 [2923260.001]
  • [Cites] J Clin Oncol. 1989 Jun;7(6):803-15 [2654333.001]
  • [Cites] N Engl J Med. 1990 May 24;322(21):1477-82 [2336074.001]
  • [Cites] Physiol Rev. 1991 Jan;71(1):93-127 [1986393.001]
  • [Cites] Metabolism. 1991 Mar;40(3):330-4 [2000047.001]
  • [Cites] J Am Geriatr Soc. 1991 Sep;39(9):853-7 [1885858.001]
  • [Cites] Arch Intern Med. 1991 Sep;151(9):1842-7 [1888251.001]
  • [Cites] J Appl Physiol (1985). 1991 Oct;71(4):1289-95 [1757351.001]
  • [Cites] Science. 1992 Mar 13;255(5050):1423-5 [1542790.001]
  • [Cites] Int J Hyperthermia. 2008 Feb;24(1):41-56 [18214768.001]
  • [Cites] Int J Hyperthermia. 2008 Feb;24(1):67-78 [18214770.001]
  • [Cites] Breast Cancer Res Treat. 2008 Apr;108(3):421-6 [17541741.001]
  • [Cites] J Clin Oncol. 2002 Mar 15;20(6):1578-83 [11896107.001]
  • [Cites] Oncol Nurs Forum. 2002 Apr;29(3):E16-25 [11979290.001]
  • [Cites] Cancer Nurs. 2002 Apr;25(2):104-9 [11984098.001]
  • [Cites] J Pain Symptom Manage. 2002 Apr;23(4):337-45 [11997203.001]
  • [Cites] Cancer Nurs. 2002 Jun;25(3):187-95 [12040227.001]
  • [Cites] Curr Treat Options Oncol. 2002 Apr;3(2):179-90 [12057081.001]
  • [Cites] J Pain Symptom Manage. 2002 Jun;23(6):501-9 [12067774.001]
  • [Cites] Ann Oncol. 2002 Jun;13(6):883-8 [12123333.001]
  • [Cites] Psychosom Med. 2002 Jul-Aug;64(4):604-11 [12140350.001]
  • [Cites] Menopause. 2002 Sep-Oct;9(5):329-34 [12218721.001]
  • [Cites] Int J Oncol. 2002 Dec;21(6):1285-92 [12429979.001]
  • [Cites] Nat Rev Cancer. 2003 Feb;3(2):110-6 [12563310.001]
  • [Cites] Mayo Clin Proc. 2003 May;78(5):603-12 [12744548.001]
  • [Cites] Br J Cancer. 2003 Jun 2;88(11):1721-6 [12771987.001]
  • [Cites] JAMA. 2003 Jun 4;289(21):2827-34 [12783913.001]
  • [Cites] Clin Sci (Lond). 2003 Jul;105(1):89-95 [12617720.001]
  • [Cites] JAMA. 2003 Jul 9;290(2):207-14 [12851275.001]
  • [Cites] Clin Cancer Res. 2003 Sep 15;9(11):4125-31 [14519635.001]
  • [Cites] J Appl Physiol (1985). 2003 Dec;95(6):2598-603 [14600165.001]
  • [Cites] Diabetologia. 2003 Nov;46(11):1483-8 [14534780.001]
  • [Cites] Cancer Res. 2003 Nov 15;63(22):8051-6 [14633738.001]
  • [Cites] Pain. 2003 Dec;106(3):357-63 [14659518.001]
  • [Cites] Immunity. 2004 Jan;20(1):59-70 [14738765.001]
  • [Cites] Front Biosci. 2004 May 1;9:1877-88 [14977594.001]
  • [Cites] Obes Res. 2004 Feb;12(2):180-6 [14981209.001]
  • [Cites] Int J Cancer. 2004 Apr 20;109(4):507-15 [14991571.001]
  • [Cites] J Surg Res. 2004 Feb;116(2):337-49 [15013374.001]
  • [Cites] Oncol Nurs Forum. 2004 Mar-Apr;31(2):202-12 [15017438.001]
  • [Cites] JAMA. 2004 Apr 7;291(13):1610-20 [15069049.001]
  • [Cites] Am J Obstet Gynecol. 1976 Sep 15;126(2):165-9 [961757.001]
  • [Cites] Br Med J. 1977 Feb 5;1(6057):353-6 [837095.001]
  • [Cites] Pediatrics. 1977 Jan;59(1):92-8 [65765.001]
  • [Cites] Environ Health Perspect. 1977 Oct;20:127-30 [598344.001]
  • [Cites] J Pain Symptom Manage. 1994 Aug;9(6):372-82 [7963790.001]
  • [Cites] J Natl Cancer Inst Monogr. 1994;(16):125-9 [7999454.001]
  • [Cites] N Engl J Med. 1995 Mar 9;332(10):621-8 [7632212.001]
  • [Cites] J Clin Endocrinol Metab. 1995 Aug;80(8):2354-8 [7629229.001]
  • [Cites] Am J Physiol. 1996 Apr;270(4 Pt 2):R693-703 [8967396.001]
  • [Cites] J Reprod Med. 1996 May;41(5):363-6 [8725765.001]
  • [Cites] J Clin Endocrinol Metab. 1996 Mar;81(3):937-41 [8772554.001]
  • [Cites] Gen Pharmacol. 1996 Sep;27(6):973-7 [8909977.001]
  • [Cites] J Appl Physiol (1985). 1996 Feb;80(2):512-5 [8929592.001]
  • [Cites] Int J Cancer. 1997 Jan 17;70(2):241-7 [9009166.001]
  • [Cites] N Engl J Med. 1997 Jul 31;337(5):295-300 [9233866.001]
  • [Cites] J Appl Physiol (1985). 1997 Aug;83(2):477-84 [9262443.001]
  • [Cites] Physiol Behav. 1997 Sep;62(3):551-6 [9272663.001]
  • [Cites] JAMA. 2006 May 3;295(17):2057-71 [16670414.001]
  • [Cites] Clin Cancer Res. 2006 May 1;12(9):2759-66 [16675568.001]
  • [Cites] Hypertension. 2008 Jun;51(6):1492-8 [18391100.001]
  • [Cites] Menopause. 2008 Jul-Aug;15(4 Pt 1):655-60 [18427355.001]
  • [Cites] J Clin Nurs. 2008 Sep;17(17):2284-7 [18705705.001]
  • [Cites] Ann Oncol. 2008 Oct;19(10):1669-80 [18522932.001]
  • [Cites] Yale J Biol Med. 1948 Jul;20(6):545-52 [18872321.001]
  • [Cites] Lancet Oncol. 2008 Dec;9(12):1143-8 [18976959.001]
  • [Cites] Int J Hyperthermia. 2008 Dec;24(8):649-62 [18608594.001]
  • [Cites] J Agric Food Chem. 2008 Dec 24;56(24):11718-26 [19049296.001]
  • [Cites] Int J Nurs Stud. 2009 May;46(5):661-8 [19128801.001]
  • [Cites] J Clin Endocrinol Metab. 2004 May;89(5):2119-26 [15126529.001]
  • [Cites] Oncol Nurs Forum. 2004 May;31(3):591-5598 [15146224.001]
  • [Cites] Growth Horm IGF Res. 2004 Aug;14(4):261-9 [15231294.001]
  • [Cites] Fertil Steril. 2004 Jul;82(1):138-44 [15237002.001]
  • [Cites] Menopause. 2004 Jul-Aug;11(4):375-81 [15243274.001]
  • [Cites] Int J Hyperthermia. 2004 Aug;20(5):503-16 [15277023.001]
  • [Cites] Proc R Soc Med. 1966 May;59(5):463-6 [5933140.001]
  • [Cites] Br Med J. 1971 Dec 11;4(5788):656-9 [5134562.001]
  • [Cites] Br Med J. 1973 Jan 27;1(5847):200-6 [4686555.001]
  • [Cites] Eur J Appl Physiol Occup Physiol. 1974;33(3):237-45 [4442403.001]
  • [Cites] Obstet Gynecol. 1975 Jun;45(6):625-7 [1095996.001]
  • [Cites] Med Hypotheses. 1998 Mar;50(3):219-26 [9578327.001]
  • [Cites] Psychooncology. 1998 Mar-Apr;7(2):129-32 [9589512.001]
  • [Cites] Science. 1998 May 29;280(5368):1378-83 [9603721.001]
  • [Cites] J Clin Oncol. 1998 Jul;16(7):2377-81 [9667254.001]
  • [Cites] J Cell Physiol. 1998 Oct;177(1):137-47 [9731754.001]
  • [Cites] Arch Intern Med. 1998 Sep 28;158(17):1870-81 [9759682.001]
  • [Cites] Oncol Nurs Forum. 1998 Oct;25(9):1577-83 [9802053.001]
  • [Cites] Obstet Gynecol. 1998 Dec;92(6):982-8 [9840563.001]
  • [Cites] J Appl Physiol (1985). 1999 May;86(5):1588-93 [10233122.001]
  • [Cites] Anticancer Res. 1999 Mar-Apr;19(2B):1427-32 [10365118.001]
  • [Cites] J Urol. 1999 Jul;162(1):98-102 [10379749.001]
  • [Cites] Am J Obstet Gynecol. 1999 Jul;181(1):66-70 [10411797.001]
  • [Cites] Cell Mol Life Sci. 2005 Jan;62(1):10-23 [15619003.001]
  • [Cites] J Natl Cancer Inst. 2005 Jan 5;97(1):30-9 [15632378.001]
  • [Cites] Mol Cell Biochem. 2004 Nov;266(1-2):37-56 [15646026.001]
  • [Cites] Eur J Clin Nutr. 2005 Feb;59(2):255-62 [15494736.001]
  • [Cites] BMJ. 2005 Mar 26;330(7493):702 [15695497.001]
  • [Cites] J Clin Oncol. 2005 May 1;23(13):3079-85 [15860867.001]
  • [Cites] Front Biosci. 2005;10:2193-216 [15970487.001]
  • [Cites] Lancet. 2005 Sep 3-9;366(9488):818-24 [16139656.001]
  • [Cites] J Clin Oncol. 2005 Oct 1;23(28):6919-30 [16192581.001]
  • [Cites] J Clin Oncol. 2005 Dec 20;23(36):9312-8 [16361630.001]
  • [Cites] Am J Med. 2005 Dec 19;118 Suppl 12B:124-30 [16414337.001]
  • [Cites] Breast J. 2006 Mar-Apr;12(2):114-22 [16509835.001]
  • [Cites] J Clin Oncol. 2006 Mar 20;24(9):1409-14 [16505409.001]
  • [Cites] J Appl Physiol (1985). 1992 Oct;73(4):1238-45 [1447065.001]
  • [Cites] Physiol Behav. 1992 Dec;52(6):1133-9 [1484872.001]
  • [Cites] J Egypt Public Health Assoc. 1992;67(5-6):579-91 [1294683.001]
  • [Cites] J Clin Oncol. 1994 Jan;12(1):155-8 [8270972.001]
  • [Cites] J Appl Physiol (1985). 1994 Jan;76(1):72-8 [8175550.001]
  • [Cites] N Engl J Med. 1994 Aug 11;331(6):347-52 [8028614.001]
  • [Cites] Exerc Sport Sci Rev. 1994;22:251-84 [7925546.001]
  • [Cites] Exp Gerontol. 1994 May-Aug;29(3-4):319-36 [7925752.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14623-8 [10588755.001]
  • [Cites] J Clin Pathol. 1999 Oct;52(10):780-1 [10674040.001]
  • [Cites] J Clin Oncol. 2000 Feb;18(4):743-53 [10673515.001]
  • [Cites] Am J Clin Nutr. 2009 May;89(5):1565S-1571S [19339393.001]
  • [Cites] Metabolism. 2009 Jun;58(6):871-6 [19375759.001]
  • [Cites] Curr Opin Investig Drugs. 2009 Jun;10(6):550-8 [19513944.001]
  • [Cites] Am J Physiol Regul Integr Comp Physiol. 2009 Aug;297(2):R485-94 [19515980.001]
  • [Cites] Climacteric. 2010 Feb;13(1):4-21 [20067430.001]
  • [Cites] Immunol Res. 2010 Mar;46(1-3):137-54 [19756410.001]
  • (PMID = 20849261.001).
  • [ISSN] 1464-5157
  • [Journal-full-title] International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
  • [ISO-abbreviation] Int J Hyperthermia
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P01 CA094045; United States / NCI NIH HHS / CA / P01 CA094045-05; United States / NCI NIH HHS / CA / R01 CA071599; United States / NCI NIH HHS / CA / R01 CA071599-10
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] England
  • [Other-IDs] NLM/ NIHMS248587; NLM/ PMC3012377
  •  go-up   go-down


7. ||........ 18%  Ramadan R, Sheps D, Esteves F, Zafari AM, Bremner JD, Vaccarino V, Quyyumi AA: Myocardial ischemia during mental stress: role of coronary artery disease burden and vasomotion. J Am Heart Assoc; 2013 Oct;2(5):e000321
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Mental stress-induced myocardial ischemia (MSIMI) is associated with adverse prognosis in patients with coronary artery disease (CAD), yet the mechanisms underlying this phenomenon remain unclear.
  • We hypothesized that compared with exercise/pharmacological stress-induced myocardial ischemia (PSIMI) that is secondary to the atherosclerotic burden of CAD, MSIMI is primarily due to vasomotor changes.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Atherosclerosis. 1997 Feb 28;129(1):111-8 [9069525.001]
  • [Cites] Circulation. 1996 Dec 1;94(11):2768-77 [8941101.001]
  • [Cites] Circulation. 1997 Dec 16;96(12):4246-53 [9416889.001]
  • [Cites] Psychosom Med. 1998 Jan-Feb;60(1):56-63 [9492241.001]
  • [Cites] J Am Coll Cardiol. 1998 May;31(6):1314-22 [9581726.001]
  • [Cites] J Am Coll Cardiol. 2006 Mar 7;47(5):987-91 [16516082.001]
  • [Cites] J Nucl Cardiol. 2008 Jul-Aug;15(4):518-25 [18674719.001]
  • [Cites] Psychosom Med. 2009 Jan;71(1):14-20 [18941131.001]
  • [Cites] Clin Cardiol. 2009 Sep;32(9):E1-6 [19672865.001]
  • [Cites] Eur Heart J. 2010 Dec;31(24):3017-23 [20729229.001]
  • [Cites] Circulation. 2002 Apr 16;105(15):1780-4 [11956119.001]
  • [Cites] J Am Coll Cardiol. 2001 Apr;37(5):1359-66 [11300447.001]
  • [Cites] Lancet. 1984 Nov 3;2(8410):1001-5 [6149394.001]
  • [Cites] Eur Heart J. 2003 Apr;24(8):690-703 [12713764.001]
  • [Cites] Br Heart J. 1980 Jul;44(1):62-6 [7426162.001]
  • [Cites] Am J Cardiol. 1983 Feb;51(3):606 [6823874.001]
  • [Cites] N Engl J Med. 1988 Apr 21;318(16):1005-12 [3352695.001]
  • [Cites] Clin Cardiol. 1989 Jan;12(1):21-4 [2912604.001]
  • [Cites] Am Heart J. 1990 Jun;119(6):1262-7 [1972310.001]
  • [Cites] Circulation. 1991 Apr;83(4 Suppl):II94-9 [2009634.001]
  • [Cites] N Engl J Med. 1991 Nov 28;325(22):1551-6 [1944439.001]
  • [Cites] J Psychosom Res. 1993 Jul;37(5):455-65 [8350288.001]
  • [Cites] Sleep. 1999 Nov 1;22(7):939-46 [10566912.001]
  • [Cites] Am J Cardiol. 1999 Dec 1;84(11):1292-7 [10614793.001]
  • [Cites] J Nucl Med. 2000 Jan;41(1):11-6 [10647599.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2000 Feb;278(2):H360-6 [10666065.001]
  • [Cites] Nat Med. 2000 Jun;6(6):606 [10835649.001]
  • [Cites] Lancet. 2000 Jul 22;356(9226):310-1 [11071190.001]
  • [Cites] Eur J Nucl Med. 2000 Dec;27(12):1760-7 [11189937.001]
  • [Cites] Am J Cardiol. 1993 Dec 15;72(18):1361-5 [8256727.001]
  • [Cites] J Am Coll Cardiol. 1994 Dec;24(7):1645-51 [7963110.001]
  • [Cites] Am J Cardiol. 1995 Mar 1;75(7):503-5 [7863998.001]
  • [Cites] Am J Cardiol. 1995 Jul 1;76(1):31-5 [7793399.001]
  • [Cites] Am J Cardiol. 1995 Jul 15;76(3):125-30 [7611145.001]
  • [Cites] J Am Coll Cardiol. 1995 Sep;26(3):639-47 [7642853.001]
  • [Cites] Circulation. 1995 Oct 15;92(8):2102-8 [7554188.001]
  • [Cites] J Am Coll Cardiol. 1995 Nov 1;26(5):1235-41 [7594037.001]
  • [Cites] JAMA. 1996 Jun 5;275(21):1651-6 [8637138.001]
  • [Cites] Circulation. 1996 Nov 15;94(10):2402-9 [8921780.001]
  • [Cites] JAMA. 1997 May 21;277(19):1521-6 [9153365.001]
  • (PMID = 24145741.001).
  • [ISSN] 2047-9980
  • [Journal-full-title] Journal of the American Heart Association
  • [ISO-abbreviation] J Am Heart Assoc
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / 5P01HL101398-02; United States / NHLBI NIH HHS / HL / 5R01HL70265-5; United States / NHLBI NIH HHS / HL / P20 HL113451
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3835239
  • [Keywords] NOTNLM ; coronary disease / ischemia / mental stress / vasoconstriction
  •  go-up   go-down


8. |||||||||. 91%  de Wit C, Griffith TM: Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses. Pflugers Arch; 2010 May;459(6):897-914
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses.
  • It is becoming increasingly evident that electrical signaling via gap junctions plays a central role in the physiological control of vascular tone via two related mechanisms (1) the endothelium-derived hyperpolarizing factor (EDHF) phenomenon, in which radial transmission of hyperpolarization from the endothelium to subjacent smooth muscle promotes relaxation, and (2) responses that propagate longitudinally, in which electrical signaling within the intimal and medial layers of the arteriolar wall orchestrates mechanical behavior over biologically large distances.
  • In the EDHF phenomenon, the transmitted endothelial hyperpolarization is initiated by the activation of Ca(2+)-activated K(+) channels channels by InsP(3)-induced Ca(2+) release from the endoplasmic reticulum and/or store-operated Ca(2+) entry triggered by the depletion of such stores.

  • HSDB. structure - HYDROGEN PEROXIDE.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20379740.001).
  • [ISSN] 1432-2013
  • [Journal-full-title] Pflügers Archiv : European journal of physiology
  • [ISO-abbreviation] Pflugers Arch.
  • [Language] eng
  • [Grant] United Kingdom / British Heart Foundation / / ; United Kingdom / Medical Research Council / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biological Factors; 0 / Connexins; 0 / Eicosanoids; 0 / Intermediate-Conductance Calcium-Activated Potassium Channels; 0 / Ion Channels; 0 / Large-Conductance Calcium-Activated Potassium Channels; 0 / Small-Conductance Calcium-Activated Potassium Channels; 0 / endothelium-dependent hyperpolarization factor; BBX060AN9V / Hydrogen Peroxide; E0399OZS9N / Cyclic AMP
  • [Number-of-references] 209
  •  go-up   go-down


9. |||||||||. 88%  Auboire L, Landy S, Perrot JY, Maïza D, Le Hello C: [A negative first-line work-up of Raynaud's phenomenon: And what if it were cancer?]. J Mal Vasc; 2010 Feb;35(1):35-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A negative first-line work-up of Raynaud's phenomenon: And what if it were cancer?].
  • Raynaud's phenomenon is a transient paroxysmal vasomotor phenomenon affecting the extremities including manifestations of ischemia.
  • It is a common phenomenon in the general population.
  • In a routine clinical situation, the first step is to differentiate Raynaud's disease from a secondary Raynaud's phenomenon, the latter requiring complementary investigations.
  • We report here the case of an 80-year-old woman who presented a secondary Raynaud's phenomenon.
  • Raynaud's phenomenon disappeared after treatment of the breast carcinoma and did not recur during the 2-year follow-up.

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Raynaud's Disease.
  • HSDB. structure - ANASTROZOLE.
  • HSDB. structure - VERAPAMIL HYDROCHLORIDE.
  • HSDB. structure - GALANTAMINE.
  • HSDB. structure - PROGESTERONE.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 Elsevier Masson SAS. All rights reserved.
  • (PMID = 19959302.001).
  • [ISSN] 0398-0499
  • [Journal-full-title] Journal des maladies vasculaires
  • [ISO-abbreviation] J Mal Vasc
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal; 0 / Estrogens; 0 / Nitriles; 0 / Triazoles; 0D3Q044KCA / Galantamine; 120511-73-1 / anastrozole; 4G7DS2Q64Y / Progesterone; CJ0O37KU29 / Verapamil; KXO2KT9N0G / Pravastatin
  • [Number-of-references] 13
  •  go-up   go-down


10. ||||||||.. 84%  Fiessinger JN: [Raynaud's phenomenon, disease or syndrome?]. Rev Prat; 2011 Sep;61(7):899-903
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Raynaud's phenomenon, disease or syndrome?].
  • Raynaud's phenomenon is a common symptom.
  • If the vasomotor symptoms are localized, a diagnosis of secondary Raynaud's phenomenon is highly probable and the main etiology is an arterial disease.
  • Occupational arterial lesions are a particularly aspect of secondary Raynaud's phenomenon.
  • Calcium channel blockers are the reference for the symptomatic treatment of Raynaud's phenomenon.

  • MedlinePlus Health Information. consumer health - Raynaud's Disease.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22039719.001).
  • [ISSN] 0035-2640
  • [Journal-full-title] La Revue du praticien
  • [ISO-abbreviation] Rev Prat
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


12. |||||||... 69%  Gadeela N, Rubinstein J, Tamhane U, Huang R, Pathak DR, Hosein HA, Rich M, Dhar G, Abela GS: The impact of circulating cholesterol crystals on vasomotor function: implications for no-reflow phenomenon. JACC Cardiovasc Interv; 2011 May;4(5):521-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The impact of circulating cholesterol crystals on vasomotor function: implications for no-reflow phenomenon.
  • [MeSH-major] Carotid Artery Injuries / etiology. Cholesterol / adverse effects. Endothelium, Vascular / injuries. No-Reflow Phenomenon / etiology. Vascular System Injuries / etiology. Vasoconstriction. Vasodilation

  • MedlinePlus Health Information. consumer health - Cholesterol.
  • HSDB. structure - Norepinephrine.
  • HSDB. structure - CHOLESTEROL.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
  • (PMID = 21596325.001).
  • [ISSN] 1876-7605
  • [Journal-full-title] JACC. Cardiovascular interventions
  • [ISO-abbreviation] JACC Cardiovasc Interv
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Vasoconstrictor Agents; 0 / Vasodilator Agents; 169D1260KM / Nitroprusside; 97C5T2UQ7J / Cholesterol; N9YNS0M02X / Acetylcholine; X4W3ENH1CV / Norepinephrine
  •  go-up   go-down


13. ||||||.... 64%  Carstens AM, Tambara EM, Matias JE, Brioschi ML, Colman D, Carstens MG: Vasomotor effect after acute intoxication with bupivacaine and levobupivacaine in rats via intraperitoneal route analyzed via digital infrared imaging. Rev Bras Anestesiol; 2011 Mar-Apr;61(2):188-93, 194-201, 101-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vasomotor effect after acute intoxication with bupivacaine and levobupivacaine in rats via intraperitoneal route analyzed via digital infrared imaging.
  • BACKGROUND AND OBJECTIVES: The study of the vasomotor effect of local anesthetics (LA) is of paramount importance for the analysis of the occurrence of cardiotoxic and neurotoxic effects, and drug interactions.
  • In order to find a safer drug than racemic bupivacaine, this study aimed to analyze digital infrared imaging of acute vasomotor effect of bupivacaine and levobupivacaine in rats intraperitoneally.
  • In Group B, there was a phenomenon of temperature increase after intraperitoneal injection of bupivacaine.
  • CONCLUSIONS: The results demonstrated that the vasomotor effect of the acute toxicity of levobupivacaine was similar to Group C with saline, through macroscopic studies by infrared digital filmmaking, and that there were vasomotor changes (vasoconstriction), with bupivacaine intoxication in relation to both Group C and Group L.
  • [MeSH-major] Anesthetics, Local / toxicity. Bupivacaine / toxicity. Vasomotor System / drug effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2011 Elsevier Editora Ltda. All rights reserved.
  • (PMID = 21474026.001).
  • [ISSN] 1806-907X
  • [Journal-full-title] Revista brasileira de anestesiologia
  • [ISO-abbreviation] Rev Bras Anestesiol
  • [Language] eng; por; spa
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Anesthetics, Local; A5H73K9U3W / levobupivacaine; Y8335394RO / Bupivacaine
  •  go-up   go-down


14. ||||||.... 58%  Mikulska D: [Diagnostic value of thermography in Raynaud's phenomenon associated with systemic lupus erythematosus]. Ann Acad Med Stetin; 2009;55(3):23-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnostic value of thermography in Raynaud's phenomenon associated with systemic lupus erythematosus].
  • INTRODUCTION: The study was undertaken to determine of thermographic parameters for the assessment of Raynaud's phenomenon in patients with systemic lupus erythematosus (SLE).
  • MATERIAL AND METHODS: The study was done in 18 patients with SLE and 16 healthy volunteers without vasomotor disorders.

  • MedlinePlus Health Information. consumer health - Lupus.
  • MedlinePlus Health Information. consumer health - Raynaud's Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20698174.001).
  • [ISSN] 1427-440X
  • [Journal-full-title] Annales Academiae Medicae Stetinensis
  • [ISO-abbreviation] Ann Acad Med Stetin
  • [Language] pol
  • [Publication-type] Controlled Clinical Trial; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


15. ||||||.... 58%  Scantlebury DC, Prasad A, Rabinstein AA, Best PJ: Prevalence of migraine and Raynaud phenomenon in women with apical ballooning syndrome (Takotsubo or stress cardiomyopathy). Am J Cardiol; 2013 May 1;111(9):1284-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prevalence of migraine and Raynaud phenomenon in women with apical ballooning syndrome (Takotsubo or stress cardiomyopathy).
  • Apical ballooning syndrome (ABS), migraine, and Raynaud phenomenon are characterized by female predominance, identifiable triggers, and, likely, vascular dysfunction.
  • We investigated the association of ABS with migraine, Raynaud phenomenon, and hormonal factors.
  • Of the patients with ABS, 4 (16%) had Raynaud phenomenon compared to no STEMI controls and 1 (2%) population control (p = 0.038).
  • In conclusion, the association of ABS with migraine and Raynaud phenomenon supports a role of vasomotor dysfunction in the pathogenesis of ABS.

  • MedlinePlus Health Information. consumer health - Migraine.
  • MedlinePlus Health Information. consumer health - Raynaud's Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2013 Elsevier Inc. All rights reserved.
  • (PMID = 23415512.001).
  • [ISSN] 1879-1913
  • [Journal-full-title] The American journal of cardiology
  • [ISO-abbreviation] Am. J. Cardiol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


16. |||||..... 53%  Kleinbongard P, Böse D, Konorza T, Steinhilber F, Möhlenkamp S, Eggebrecht H, Baars T, Degen H, Haude M, Levkau B, Erbel R, Heusch G: Acute vasomotor paralysis and potential downstream effects of paclitaxel from stents implanted for saphenous vein aorto-coronary bypass stenosis. Basic Res Cardiol; 2011 Jun;106(4):681-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acute vasomotor paralysis and potential downstream effects of paclitaxel from stents implanted for saphenous vein aorto-coronary bypass stenosis.
  • Such acute downstream vascular paralysis could be beneficial in preventing a no-reflow phenomenon in patients undergoing stenting.

  • MedlinePlus Health Information. consumer health - Coronary Artery Bypass Surgery.
  • HSDB. structure - TAXOL.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21472462.001).
  • [ISSN] 1435-1803
  • [Journal-full-title] Basic research in cardiology
  • [ISO-abbreviation] Basic Res. Cardiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 33069-62-4 / Paclitaxel; 333DO1RDJY / Serotonin; 54397-85-2 / Thromboxane B2
  •  go-up   go-down


17. |||||..... 52%  Donoyama N, Ohkoshi N: Electroacupuncture therapy for arthralgia and Raynaud's phenomenon in a patient with systemic lupus erythematosus. Acupunct Med; 2010 Mar;28(1):49-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Electroacupuncture therapy for arthralgia and Raynaud's phenomenon in a patient with systemic lupus erythematosus.
  • A 45-year-old woman with systemic lupus erythematosus presented with multiple arthralgia, coldness in fingers and toes, and Raynaud's phenomenon.
  • Cold provocation testing was conducted before and after EA sessions to determine the vasomotor response.
  • In the last EA session, the patient reported that the cold in her fingers and toes had eased and Raynaud's phenomenon, in which nail colour tone changed from white to red, had disappeared.


18. |||....... 35%  Pradhan RK, Chakravarthy VS: Desynchronized vasomotion and desynchronized fiber activation pattern enhance oxygenation in a model of skeletal muscle. J Theor Biol; 2009 Jul 21;259(2):242-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Optimal oxygenation is observed when both neuronal network and vasomotor network exhibit desynchronous activity.
  • The model provides interesting insights into the phenomenon of muscle fatigue.
  • [MeSH-major] Models, Biological. Muscle, Skeletal / physiology. Oxygen Consumption / physiology. Vasomotor System / physiology

  • COS Scholar Universe. author profiles.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19303886.001).
  • [ISSN] 1095-8541
  • [Journal-full-title] Journal of theoretical biology
  • [ISO-abbreviation] J. Theor. Biol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


19. |||....... 35%  Gregorini L, Marco J, Heusch G: Peri-interventional coronary vasomotion. J Mol Cell Cardiol; 2012 Apr;52(4):883-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A percutaneous coronary intervention (PCI) is a unique condition to study the effects of ischemia and reperfusion in patients with severe coronary atherosclerosis when coronary vasomotor function is compromised by loss of endothelial and autoregulatory vasodilation.
  • Coronary vasoconstriction in our studies was a diffuse phenomenon and involved not only the culprit lesion but also vessels with angiographically not visible plaques.
  • Intracoronary α-blockade also attenuated the no-reflow phenomenon following primary PCI.
  • [MeSH-major] Coronary Circulation / physiology. No-Reflow Phenomenon / physiopathology

  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2011 Elsevier Ltd. All rights reserved.
  • (PMID = 21971073.001).
  • [ISSN] 1095-8584
  • [Journal-full-title] Journal of molecular and cellular cardiology
  • [ISO-abbreviation] J. Mol. Cell. Cardiol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  •  go-up   go-down


20. |||....... 33%  Kleinbongard P, Baars T, Heusch G: Calcium antagonists in myocardial ischemia/reperfusion--update 2012. Wien Med Wochenschr; 2012 Jul;162(13-14):302-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The present article briefly reviews the processes underlying excitation-contraction coupling in cardiomyocytes and vascular smooth muscle cells, their perturbations during reversible and irreversible myocardial ischemia and reperfusion, notably the pathogenetic role of increased intracellular calcium concentrations, and finally the beneficial effects of calcium antagonists on the impairment of coronary vasomotor tone, on cardiac contractile dysfunction and on myocardial infarction.
  • [MeSH-minor] Coronary Circulation / drug effects. Coronary Circulation / physiology. Humans. Muscle, Smooth, Vascular / drug effects. Muscle, Smooth, Vascular / physiology. Myocardial Contraction / drug effects. Myocardial Contraction / physiology. Myocardial Infarction / drug therapy. Myocardial Infarction / physiopathology. Myocardial Stunning / drug therapy. Myocardial Stunning / physiopathology. Myocytes, Cardiac / drug effects. Myocytes, Cardiac / physiology. No-Reflow Phenomenon / drug therapy. No-Reflow Phenomenon / physiopathology. Vascular Resistance / drug effects. Vascular Resistance / physiology

  • HSDB. structure - CALCIUM, ELEMENTAL.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22695811.001).
  • [ISSN] 1563-258X
  • [Journal-full-title] Wiener medizinische Wochenschrift (1946)
  • [ISO-abbreviation] Wien Med Wochenschr
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Austria
  • [Chemical-registry-number] 0 / Calcium Channel Blockers; SY7Q814VUP / Calcium
  •  go-up   go-down


21. |||....... 32%  Payne SJ, Oakes CN, Park CS: Vasomotion does inhibit mass exchange between axisymmetric blood vessels and tissue. J Theor Biol; 2012 Jun 7;302:1-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Vasomotion, the name given to the physiological phenomenon whereby blood vessel walls exhibit rhythmic oscillations in diameter, is a complex process and very poorly understood.
  • [MeSH-major] Blood Vessels / physiology. Capillary Permeability / physiology. Models, Cardiovascular. Vasomotor System / physiology

  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2012 Elsevier Ltd. All rights reserved.
  • (PMID = 22619749.001).
  • [ISSN] 1095-8541
  • [Journal-full-title] Journal of theoretical biology
  • [ISO-abbreviation] J. Theor. Biol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


22. |||....... 31%  Di Fiore DP, Beltrame JF: Chest pain in patients with 'normal angiography': could it be cardiac? Int J Evid Based Healthc; 2013 Mar;11(1):56-68
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this review, the potential non-cardiac and cardiac causes for the chest pain in patients with normal angiography are briefly discussed with an in-depth focus on coronary vasomotor disorders including coronary artery spasm (variant angina) and microvascular disorders such as syndrome X, microvascular angina, the coronary slow flow phenomenon and microvascular spasm.

  • MedlinePlus Health Information. consumer health - Chest Pain.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2013 The Authors. International Journal of Evidence-Based Healthcare © 2013 The Joanna Briggs Institute.
  • (PMID = 23448331.001).
  • [ISSN] 1744-1609
  • [Journal-full-title] International journal of evidence-based healthcare
  • [ISO-abbreviation] Int J Evid Based Healthc
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Australia
  •  go-up   go-down


23. |||....... 31%  Pendyala LK, Yin X, Li J, Chen JP, Chronos N, Hou D: The first-generation drug-eluting stents and coronary endothelial dysfunction. JACC Cardiovasc Interv; 2009 Dec;2(12):1169-77
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recently, a growing body of clinical data has shown that the first generation of drug-eluting stents (1st-gen DES) implantation could elicit coronary conduit artery vasomotor dysfunction at nonstented reference segments as late as 12 months after implantation compared with that seen with bare-metal stents.
  • The mechanism of this phenomenon is still not fully understood.

  • MedlinePlus Health Information. consumer health - Coronary Artery Disease.
  • HSDB. structure - TAXOL.
  • HSDB. structure - SIROLIMUS.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20129542.001).
  • [ISSN] 1876-7605
  • [Journal-full-title] JACC. Cardiovascular interventions
  • [ISO-abbreviation] JACC Cardiovasc Interv
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cardiovascular Agents; 33069-62-4 / Paclitaxel; W36ZG6FT64 / Sirolimus
  • [Number-of-references] 65
  •  go-up   go-down


24. |||....... 31%  da Silva OG, Rossignoli Pde S, Carrillo-Sepúlveda MA, Barreto-Chaves ML, Chies AB: Involvement of the AT1 receptor in the venoconstriction induced by angiotensin II in both the inferior vena cava and femoral vein. Peptides; 2011 Jan;32(1):112-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although angiotensin II-induced venoconstriction has been demonstrated in the rat vena cava and femoral vein, the angiotensin II receptor subtypes (AT(1) or AT(2)) that mediate this phenomenon have not been precisely characterized.
  • Therefore, the present study aimed to characterize the pharmacological receptors involved in the angiotensin II-induced constriction of rat venae cavae and femoral veins, as well as the opposing effects exerted by locally produced prostanoids and NO upon induction of these vasomotor responses.

  • HSDB. structure - LOSARTAN POTASSIUM.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20955746.001).
  • [ISSN] 1873-5169
  • [Journal-full-title] Peptides
  • [ISO-abbreviation] Peptides
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Imidazoles; 0 / Pyridines; 0 / Receptor, Angiotensin, Type 1; 11128-99-7 / Angiotensin II; 130663-39-7 / PD 123319; JMS50MPO89 / Losartan; V55S2QJN2X / NG-Nitroarginine Methyl Ester
  •  go-up   go-down


25. |||....... 31%  Hautamäki H, Piirilä P, Haapalahti P, Tuomikoski P, Sovijärvi AR, Ylikorkala O, Mikkola TS: Cardiovascular autonomic responsiveness in postmenopausal women with and without hot flushes. Maturitas; 2011 Apr;68(4):368-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: During menopausal transition autonomic balance is known to shift towards sympathetic dominance, but the role of vasomotor hot flushes in this phenomenon is not understood.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 21310559.001).
  • [ISSN] 1873-4111
  • [Journal-full-title] Maturitas
  • [ISO-abbreviation] Maturitas
  • [Language] eng
  • [Publication-type] Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  •  go-up   go-down


26. |||....... 31%  Dziewulska D, Lewandowska E: Pericytes as a new target for pathological processes in CADASIL. Neuropathology; 2012 Oct;32(5):515-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Since in capillaries pericytes regulate vessel contractility, their degeneration can also cause defective vasomotor reactivity, the phenomenon observed very early in CADASIL, before development of histopathological changes in vessel walls.

  • HSDB. structure - URANYL ACETATE.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2012 Japanese Society of Neuropathology.
  • (PMID = 22239429.001).
  • [ISSN] 1440-1789
  • [Journal-full-title] Neuropathology : official journal of the Japanese Society of Neuropathology
  • [ISO-abbreviation] Neuropathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Coloring Agents; 0 / Organometallic Compounds; 285PN2K1AO / uranyl acetate
  •  go-up   go-down


27. |||....... 31%  Lazdam M, Lewandowski AJ, Kylintireas I, Cunnington C, Diesch J, Francis J, Trevitt C, Neubauer S, Singhal A, Leeson P: Impaired endothelial responses in apparently healthy young people associated with subclinical variation in blood pressure and cardiovascular phenotype. Am J Hypertens; 2012 Jan;25(1):46-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: A phenomenon of endothelial impairment, independent of classical cardiovascular risk factors, has been observed in young people.
  • METHODS: Endothelial vasomotor responses were assessed by brachial artery flow-mediated dilatation (FMD) at age 15 years in 47 subjects (22 males) who returned for a repeated measurement at age 25.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21976278.001).
  • [ISSN] 1941-7225
  • [Journal-full-title] American journal of hypertension
  • [ISO-abbreviation] Am. J. Hypertens.
  • [Language] eng
  • [Grant] United Kingdom / British Heart Foundation / / FS/06/024; United Kingdom / British Heart Foundation / / FS/11/65/28865; United Kingdom / Medical Research Council / / G0700349; United Kingdom / Medical Research Council / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


28. |||....... 31%  Li J, Cao YX, Chen KL, Cao L, Ma Z, Xu CB: Regional variations of vasomotion to G-protein coupled receptor agonists following heat stress in rats. J Pharm Pharmacol; 2010 Mar;62(3):315-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSIONS: The vasomotor responses to the G-protein coupled receptor agonists with altered vascular contractions and relaxations were different in rat renal, femoral and mesenteric arteries after heat stress.
  • This might have contributed to the redistribution of blood flow and aids understanding of the preconditioning phenomenon.

  • MedlinePlus Health Information. consumer health - Heat Illness.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20487214.001).
  • [ISSN] 2042-7158
  • [Journal-full-title] The Journal of pharmacy and pharmacology
  • [ISO-abbreviation] J. Pharm. Pharmacol.
  • [Language] eng
  • [Publication-type] Comparative Study; In Vitro; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Adrenergic alpha-Agonists; 0 / Neurotransmitter Agents; 0 / Receptors, Endothelin; 0 / Receptors, G-Protein-Coupled; 0 / Serotonin Receptor Agonists; 83652-28-2 / Calcitonin Gene-Related Peptide
  •  go-up   go-down


29. |||....... 31%  Harris LK: IFPA Gabor Than Award lecture: Transformation of the spiral arteries in human pregnancy: key events in the remodelling timeline. Placenta; 2011 Mar;32 Suppl 2:S154-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • During human pregnancy, the uterine spiral arteries are progressively remodelled to form dilated conduits lacking maternal vasomotor control.
  • This phenomenon ensures that a constant supply of blood is delivered to the materno-fetal interface at an optimal velocity for nutrient exchange.

  • MedlinePlus Health Information. consumer health - Pregnancy.
  • COS Scholar Universe. author profiles.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2011 Elsevier Ltd. All rights reserved.
  • (PMID = 21167598.001).
  • [ISSN] 1532-3102
  • [Journal-full-title] Placenta
  • [ISO-abbreviation] Placenta
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / G0900991
  • [Publication-type] Lectures
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Angiopoietins; 0 / Blood Coagulation Factors; 0 / Chemotactic Factors; 0 / Culture Media, Conditioned; 0 / Peptides; 0 / Vascular Endothelial Growth Factor C; 82115-62-6 / Interferon-gamma; 9007-58-3 / Elastin; EC 3.4.24.- / Matrix Metalloproteinases, Secreted; EC 3.4.24.65 / Matrix Metalloproteinase 12
  •  go-up   go-down


30. |||....... 30%  Rajendran S, Willoughby SR, Chan WP, Liberts EA, Heresztyn T, Saha M, Marber MS, Norman RJ, Horowitz JD: Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Atherosclerosis; 2009 Jun;204(2):509-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We sought to determine whether polycystic ovary syndrome (PCOS), which has been postulated as a cardiovascular risk factor in women, is independently associated with this phenomenon.
  • However, vasomotor responses to nitroglycerin and circulating EPC counts did not vary between groups.

  • MedlinePlus Health Information. consumer health - Obesity.
  • MedlinePlus Health Information. consumer health - Polycystic Ovary Syndrome.
  • HSDB. structure - NITRIC OXIDE.
  • HSDB. structure - ALBUTEROL.
  • HSDB. structure - MALONALDEHYDE.
  • HSDB. structure - NITROGLYCERIN.
  • HSDB. structure - (L)-ARGININE.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19027116.001).
  • [ISSN] 1879-1484
  • [Journal-full-title] Atherosclerosis
  • [ISO-abbreviation] Atherosclerosis
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Inflammation Mediators; 0 / Nitric Oxide Donors; 0 / Vasodilator Agents; 169D1260KM / Nitroprusside; 30344-00-4 / N,N'-dimethylarginine; 31C4KY9ESH / Nitric Oxide; 4Y8F71G49Q / Malondialdehyde; 61D2G4IYVH / Adenosine Diphosphate; 9007-41-4 / C-Reactive Protein; 94ZLA3W45F / Arginine; G59M7S0WS3 / Nitroglycerin; QF8SVZ843E / Albuterol
  •  go-up   go-down


31. ||........ 18%  Lam CF, Chang PJ, Chen YA, Yeh CY, Tsai YC: Inhibition of ATP-sensitive potassium channels attenuates propofol-induced vasorelaxation. Crit Care Resusc; 2010 Sep;12(3):186-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, the exact underlying molecular mechanisms of this clinically important phenomenon remain unclear.
  • DESIGN, SETTING AND SUBJECTS: Ex vivo assessment of vasomotor function in rat aortic rings, with or without endothelium, after addition of propofol or etomidate.

  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21261577.001).
  • [ISSN] 1441-2772
  • [Journal-full-title] Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine
  • [ISO-abbreviation] Crit Care Resusc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


top


2. Definitions


3. Related RMF webpages


terms of use | advertising programs | contact us
© 2014 RecentMedicalFindings


Connect with the


RMF


audience;




Post your ad here!